| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 12/12/2013 | US20130330308 Feed additive composition |
| 12/12/2013 | US20130330306 Composition containing human umbilical cord blood-derived mesenchymal stem cell for inducing differentiation and proliferation of neural precursor cells or neural stem cells to neural cells |
| 12/12/2013 | US20130330295 Antigenic gly1 polypeptide |
| 12/12/2013 | US20130330294 Serum Amyloid A (SAA) Overrides Regulatory T Cells (TREG) Anergy |
| 12/12/2013 | US20130330281 Pharmaceutical Compositions |
| 12/12/2013 | US20130330277 Methods of using sustained release aminopyridine compositions |
| 12/12/2013 | DE202013009988U1 Biologischer antimykotischer Nagellack, Nagellasur, und/oder Nagelhärter Biological antifungal nail polish, nail varnish, and / or nail hardener |
| 12/11/2013 | EP2671875A1 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof |
| 12/11/2013 | EP2671589A1 Medicinal agent for prevention or treatment of diseases associated with intraocular neovascularization and/or intraocular vascular hyperpermeability |
| 12/11/2013 | EP2671578A1 Prophylactic or therapeutic drug for peripheral neuropathy caused by anticancer agent |
| 12/11/2013 | EP2670426A2 Multimodal trail molecules and uses in cellular therapies |
| 12/11/2013 | EP2670417A1 Methods and compositions for treating bacterial infections with iron chelators |
| 12/11/2013 | EP2670411A1 Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (ctgf) |
| 12/11/2013 | EP2670408A1 (5s,8s)-3-(4'-chlor-3'-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one (compound a) for treatment |
| 12/11/2013 | EP2670407A2 Treatment of bacterial infections |
| 12/11/2013 | EP2670405A1 Combinations comprising macitentan for the treatment of glioblastoma multiforme |
| 12/11/2013 | EP2670395A1 Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases |
| 12/11/2013 | CN103443106A Novel octahydrothienoquinoline derivatives, pharmaceutical compositions comprising the derivatives and uses of the pharmaceutical compositions |
| 12/11/2013 | CN103442717A Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases |
| 12/11/2013 | CN103442710A Combination of checkpoint kinase 1 inhibitors and WEE1 kinase inhibitors |
| 12/11/2013 | CN103436992A Method for preparing nano drug-carrying capsule-loaded alginate fibers |
| 12/11/2013 | CN103436582A Konjac polypeptide extract, as well as preparation method and application thereof |
| 12/11/2013 | CN103432596A Method for researching abirritation mechanism of Chinese herbal medicinal ingredients of Xinhuang tablets |
| 12/11/2013 | CN103432584A Cooling and itching relieving composition and paper towel employing same |
| 12/11/2013 | CN103432101A Nanosuspension osmotic pump type sustained-release system of insoluble drugs and preparation method thereof |
| 12/11/2013 | CN103432073A Tumor-targeted nanometer preparation and preparation method thereof |
| 12/11/2013 | CN103432072A In-dissolvable drug food protein stabilizing suspension for injection and preparation method thereof |
| 12/11/2013 | CN102793929B Method for preparing stable amorphous drug preparation |
| 12/11/2013 | CN101657101B Treatment of comorbid premature ejaculation and erectile dysfunction |
| 12/10/2013 | US8604164 High purity lipopeptides |
| 12/10/2013 | US8604070 Use of inhibitors of the renin-angiotensin system |
| 12/10/2013 | US8604041 Method of treating panic disorder |
| 12/10/2013 | US8604028 Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof |
| 12/10/2013 | US8603778 Anti-TNF antibodies, compositions, methods and uses |
| 12/10/2013 | US8603546 Herbal supplement for increased muscle strength and endurance for athletes |
| 12/10/2013 | US8603520 Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors |
| 12/10/2013 | US8603488 Photoautotrophic growth of microalgae for omega-3 fatty acid production |
| 12/10/2013 | US8603464 Alkaline phosphatase to reduce weight gain or induce weight loss |
| 12/10/2013 | US8603455 Removal promoters and inhibitor for apoptosis cells in vivo |
| 12/10/2013 | US8603453 Antimicrobial polymeric biguanide and acidic co-polymer composition and method of use |
| 12/10/2013 | US8603076 Microfabricated nanopore device for sustained release of therapeutic agent |
| 12/10/2013 | CA2736615C Method for classifying and treating physiologic brain imbalances using quantitative eeg |
| 12/10/2013 | CA2609336C Quadraphasic continuous graduated estrogen contraceptive |
| 12/10/2013 | CA2557848C Ion binding compositions |
| 12/10/2013 | CA2538104C Use of xenon with hypothermia for treating neonatal asphyxia |
| 12/10/2013 | CA2478612C Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist |
| 12/10/2013 | CA2465314C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 12/10/2013 | CA2465040C An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 12/10/2013 | CA2464700C Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 12/10/2013 | CA2453173C Mycobacterial antigens expressed during latency |
| 12/10/2013 | CA2451026C Mycobacterial antigens expressed under low oxygen tension |
| 12/10/2013 | CA2415325C Preventing airway mucus production by administration of egf-r antagonists |
| 12/10/2013 | CA2385528C Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 12/05/2013 | WO2013181462A1 Use of amg 900 for the treatment of cancer |
| 12/05/2013 | WO2013181232A2 Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases |
| 12/05/2013 | WO2013181087A2 Multimeric complexes with improved in vivo stability, pharmacokinetics and efficacy |
| 12/05/2013 | WO2013180310A1 Drug for preventing and/or treating polycystic kidney disease |
| 12/05/2013 | WO2013180274A1 Chemotherapy selection method for stomach cancer patients |
| 12/05/2013 | WO2013180240A1 Medicine comprising combination of general anesthetic drug and hydrogen |
| 12/05/2013 | WO2013178763A1 Methods for treating vestibulotoxicity |
| 12/05/2013 | WO2013147649A3 Inhibitors of the pi3k/akt/ikk/nf-kb signalling pathway, pharmaceutically acceptable salts thereof and compositions containing said inhibitors for the prophylaxis and treatment of viral diseases |
| 12/05/2013 | US20130324610 Cathepsin cysteine protease inhibitors |
| 12/05/2013 | US20130324609 Depression disorder therapeutics with creatine analogs |
| 12/05/2013 | US20130324608 Methods and compositions for treating, reducing or preventing damage to the nervous system of animals |
| 12/05/2013 | US20130324597 Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections |
| 12/05/2013 | US20130324594 Methods and compositions for preventing and treating auditory dysfunctions |
| 12/05/2013 | US20130324580 Anti-Cancer Agents Synthesized Based On Miliusane Compounds |
| 12/05/2013 | US20130324578 Administration regime for nitrocatechols |
| 12/05/2013 | US20130324576 Therapeutic compounds |
| 12/05/2013 | US20130324565 Organic compounds |
| 12/05/2013 | US20130324562 Fused bicyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors |
| 12/05/2013 | US20130324559 Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases |
| 12/05/2013 | US20130324552 Chemokine cxcr4 receptor modulators and used related thereto |
| 12/05/2013 | US20130324551 Thiazolylphenyl-benzenesulfonamido derivatives as kinase inhibitors |
| 12/05/2013 | US20130324534 Combination of brimonidine and timolol for topical ophthalmic use |
| 12/05/2013 | US20130324526 [1,2,4] triazolo [4,3-b] pyridazine compounds as inhibitors of the c-met tyrosine kinase |
| 12/05/2013 | US20130324514 Indanyloxyphenylcyclopropanecarboxylic acids |
| 12/05/2013 | US20130324509 Spinal cord injury, inflammation, and immune-disease: local controlled release of therapeutic agents |
| 12/05/2013 | US20130324507 Novel (aza)Benzhydryl Ether Derivatives, Their Process of Preparation and Their Use as H4-Receptor Ligands for Therapeutical Applications |
| 12/05/2013 | US20130324506 New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands |
| 12/05/2013 | US20130324504 Antispasmodic 1,2-diols and 1,2,3-triols |
| 12/05/2013 | US20130324503 Method of identifying and treating a person having a predisposition to or afflicted with Parkinson disease |
| 12/05/2013 | US20130324501 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 12/05/2013 | US20130324500 Spinal cord injury, inflammation and immune-disease: local controlled release of therapeutic agents |
| 12/05/2013 | US20130324485 Method of Determining the Probability of a Therapeutic Response in Cancer Chemotherapy with Cardiac Glycoside |
| 12/05/2013 | US20130324482 Compstatin analogs for treatment of rhinosinusitis and nasal polyposis |
| 12/05/2013 | US20130324475 Arthroscopic Irrigation Solution and Method for Peripheral Vasoconstriction and Inhibition of Pain and Inflammation |
| 12/05/2013 | US20130324468 METHODS OF TREATING DISEASES ASSOCIATED WITH PPARy |
| 12/05/2013 | US20130324464 Aryl glycoside compound, preparation method and use thereof |
| 12/05/2013 | US20130324461 Methods and compositions for preventing or treating obesity |
| 12/05/2013 | US20130324457 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof |
| 12/05/2013 | US20130323755 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer |
| 12/05/2013 | US20130323328 Pharmaceutical Preparation Containing Selenite or Selenite-Containing Compounds for Treating Cervical Dysplasia or Carcinomas |
| 12/05/2013 | US20130323323 Therapeutic Method and Associated Compound for Augmenting the Liver's Metabolization of Oxygen-Modified Toxins |
| 12/05/2013 | US20130323318 Protein free surfactant composition for pulmonary diseases and a process for preparing the same |
| 12/05/2013 | US20130323314 Novel Nanoparticles of Lactoferrin Useful for Preparing a Pharmaceutical Composition Facilitating Easy Delivery of the Drug and a Process for Preparing the Same |
| 12/05/2013 | US20130323302 Treatment of amd using aav sflt-1 |
| 12/05/2013 | US20130323300 Therapeutic composition for treatment of glioblastoma |
| 12/05/2013 | US20130323297 Local administration of gallium compositions to treat pain |
| 12/05/2013 | US20130323288 Pharmaceutical formulation for bedwetting and method of use thereof |